Arvinas (ARVN) Shares Outstanding (Diluted Average) (2019 - 2026)

Arvinas (ARVN) recorded quarterly Shares Outstanding (Diluted Average) of $64.0 million in Q1 2026, down 9.73% quarter-over-quarter from $70.9 million in Q4 2025, and down 11.97% on a YoY basis from $72.7 million in Q1 2025.

Arvinas (ARVN) Shares Outstanding (Diluted Average) (2019 - 2026) Analysis & Trends

Arvinas' Shares Outstanding (Diluted Average) history runs 8 years deep, the most recent figure standing at $64.0 million for Q1 2026.

  • In Q1 2026, Shares Outstanding (Diluted Average) fell 11.97% year-over-year to $64.0 million; the TTM figure through Mar 2026 stood at $64.0 million (down 11.97% YoY), while the FY2025 annual figure was $70.9 million, down 1.39% from the prior year.
  • Shares Outstanding (Diluted Average) was $64.0 million for Q1 2026 at Arvinas, down from $70.9 million in the prior quarter.
  • In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $73.2 million in Q3 2025 to a low of $53.0 million in Q1 2022.
  • Historically, Shares Outstanding (Diluted Average) has averaged $62.9 million across 5 years, with a median of $64.0 million in 2026.
  • The sharpest annual moves came in 2024 and 2026: Shares Outstanding (Diluted Average) surged 34.52% in 2024, then declined 11.97% in 2026.
  • A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $53.2 million in 2022, then grew by 4.32% to $55.5 million in 2023, then advanced by 29.55% to $71.9 million in 2024, then retreated by 1.39% to $70.9 million in 2025, then dropped by 9.73% to $64.0 million in 2026.
  • The last three Shares Outstanding (Diluted Average) figures came in at $64.0 million (Q1 2026), $70.9 million (Q4 2025), and $73.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 4,489.46 Bn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 810.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 118.76 Bn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 1.48 Bn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 256.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 92.44 Mn
10 Arvinas 492.16 Mn -122.74 Mn - 64.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 64.00 Mn
Dec 31, 2025 70.90 Mn
Sep 30, 2025 73.20 Mn
Jun 30, 2025 73.00 Mn
Mar 31, 2025 72.70 Mn
Dec 31, 2024 71.90 Mn
Sep 30, 2024 71.90 Mn
Jun 30, 2024 71.70 Mn
Mar 31, 2024 71.70 Mn
Dec 31, 2023 55.50 Mn
Sep 30, 2023 54.10 Mn
Jun 30, 2023 53.40 Mn
Mar 31, 2023 53.30 Mn
Dec 31, 2022 53.20 Mn
Sep 30, 2022 53.20 Mn
Jun 30, 2022 53.10 Mn
Mar 31, 2022 53.00 Mn
Dec 31, 2021 50.00 Mn
Sep 30, 2021 49.80 Mn
Jun 30, 2021 48.70 Mn